Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
SLC26A1 directs sulfate homeostasis in health and disease.
Journal: Current opinion in nephrology and hypertension
Published: October 07, 2025
Interleukin-16 is increased in dialysis patients but is not a cardiovascular risk factor.
Journal: Scientific reports
Published: December 27, 2023
SLC26A1 is a major determinant of sulfate homeostasis in humans.
Journal: The Journal of clinical investigation
Published: May 23, 2022
New Insights into the Pivotal Roles of Claudins in Proximal Tubule Electrolyte Reabsorption.
Journal: Journal of the American Society of Nephrology : JASN
Published: March 10, 2022
Dominant negative mutation in oxalate transporter SLC26A6 associated with enteric hyperoxaluria and nephrolithiasis.
Journal: Journal of medical genetics
Published: October 11, 2021
Deletion of Cdh16 Ksp-cadherin leads to a developmental delay in the ability to maximally concentrate urine in mouse.
Journal: American journal of physiology. Renal physiology
Published: May 03, 2021
Author Reply to Comment on "Assessment of Plasma Oxalate Concentration in Patients With CKD" by Oka et al.
Journal: Kidney international reports
Published: February 11, 2021
High Oxalate Concentrations Correlate with Increased Risk for Sudden Cardiac Death in Dialysis Patients.
Journal: Journal of the American Society of Nephrology : JASN
Published: December 25, 2020
Assessment of Plasma Oxalate Concentration in Patients With CKD.
Journal: Kidney international reports
Published: July 27, 2020
Enteric Oxalate Secretion Mediated by Slc26a6 Defends against Hyperoxalemia in Murine Models of Chronic Kidney Disease.
Journal: Journal of the American Society of Nephrology : JASN
Published: January 28, 2020
Last Updated: 09/26/2026